This inventor holds 1 USPTO granted patent. Top assignee: Jiangnan University. Active years: 2019.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2019
Title: Kunpeng Li: Innovator in Biocatalysis
Introduction
Kunpeng Li is a prominent inventor based in Wuxi, China. He has made significant contributions to the field of biocatalysis, particularly in the synthesis of chiral alcohols. His innovative work has led to the development of methods that enhance the efficiency and stability of enzymatic reactions.
Latest Patents
Kunpeng Li holds a patent for "Carbonyl reductase oligomers and their application in synthesis of chiral alcohols." This patent discloses methods for synthesizing chiral alcohols using Sortase A-mediated oxidoreductase oligomers. The invention demonstrates that these oligomers serve as effective biocatalysts, significantly improving catalytic activity and thermal stability compared to wild-type enzymes. The oxidoreductase oligomers exhibit a 6-8 fold increase in specific activity and a T-value that is 6-12°C higher than that of the wild-type enzymes. This advancement allows for the asymmetric transformation to produce (S)-1-phenyl-1,2-ethanediol or (R)-1-phenethyl alcohol with an optical purity of 98%-100% and a yield of 98%-99% within 3-6 hours.
Career Highlights
Kunpeng Li is affiliated with Jiangnan University, where he continues to advance research in biocatalysis. His work has garnered attention for its practical applications in the synthesis of valuable chiral compounds.
Collaborations
He collaborates with notable colleagues, including Rongzhen Zhang and Yan Xu, who contribute to his research endeavors.
Conclusion
Kunpeng Li's innovative contributions to biocatalysis and his patented methods for synthesizing chiral alcohols highlight his role as a leading inventor in this field. His work not only enhances the efficiency of enzymatic processes but also paves the way for future advancements in biocatalytic applications.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile